Certified by Founder Lodge
Soleus Capital Management, L.P.
United States - Greenwich, CT
INVESTOR
1 Disclosed Funding Rounds $41,500,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The Firm seeks to generate superior risk-adjusted returns through idiosyncratic, catalyst-driven investing with a focus on complex and niche opportunities in the Public and Private space.
| Company | Date | Round | Raised |
|---|---|---|---|
 Parse Biosciences |
February, 15 ,2022 | Series B | $41,500,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Pillar Biosciences Incorporated |
May, 28 ,2025 | Unknown | $34,500,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
